CoverOne includes a Patient Assistance Program (PAP) that provides TEPMETKO® (tepotinib) at no charge to patients who meet certain insurance (i.e., uninsured), income, and residency eligibility criteria.

  • To determine patient eligibility, providers should complete and fax the CoverOne TEPMETKO Enrollment Form prior to treatment to 844-501-0062
  • An Access Navigator will notify you as soon as possible about the patient’s eligibility status.
  • If eligible, the CoverOne PAP will ship the free supply of TEPMETKO to the patient

NOTE: The CoverOne patient assistance program is a philanthropic program for patients in need, and is not contingent on any past or future commercial sale.